Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release

Kyle T. Hufziger, Fathima Shazna Thowfeik, David J. Charboneau, Ismael Nieto, William G. Dougherty, W. Scott Kassel, Timothy J. Dudley, Edward J. Merino, Elizabeth T. Papish, Jared J. Paul

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release'. Together they form a unique fingerprint.

Keyphrases

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science